10x Genomics Total Current Liabilities 2018-2025 | TXG
10x Genomics total current liabilities from 2018 to 2025. Total current liabilities can be defined as the sum of all liabilities classified as current for having maturities of less than one year.
| 10x Genomics Annual Total Current Liabilities (Millions of US $) |
|
|---|---|
| 2024 | $118 |
| 2023 | $127 |
| 2022 | $131 |
| 2021 | $110 |
| 2020 | $118 |
| 2019 | $63 |
| 2018 | $32 |
| 2017 | $0 |
| 10x Genomics Quarterly Total Current Liabilities (Millions of US $) |
|
|---|---|
| 2025-03-31 | $108 |
| 2024-12-31 | $118 |
| 2024-09-30 | $121 |
| 2024-06-30 | $111 |
| 2024-03-31 | $109 |
| 2023-12-31 | $127 |
| 2023-09-30 | $105 |
| 2023-06-30 | $98 |
| 2023-03-31 | $112 |
| 2022-12-31 | $131 |
| 2022-09-30 | $127 |
| 2022-06-30 | $118 |
| 2022-03-31 | $94 |
| 2021-12-31 | $110 |
| 2021-09-30 | $100 |
| 2021-06-30 | $113 |
| 2021-03-31 | $121 |
| 2020-12-31 | $118 |
| 2020-09-30 | $146 |
| 2020-06-30 | $122 |
| 2020-03-31 | $59 |
| 2019-12-31 | $63 |
| 2019-09-30 | |
| 2019-06-30 | |
| 2019-03-31 | |
| 2018-12-31 | $32 |
| 2017-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.468B | $0.611B |
| 10x Genomics Inc. is a life science technology company. It develops and sells instruments, consumables and software for analyzing biological systems. 10x Genomics Inc. is based in Pleasanton, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $45.919B | 58.42 |
| Doximity (DOCS) | United States | $11.431B | 52.92 |
| Hims & Hers Health (HIMS) | United States | $10.838B | 112.61 |
| Tempus AI (TEM) | United States | $10.042B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.445B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.743B | 58.48 |
| Hinge Health (HNGE) | United States | $3.360B | 0.00 |
| Privia Health (PRVA) | United States | $2.603B | 177.92 |
| Enovis (ENOV) | United States | $1.886B | 10.52 |
| Phreesia (PHR) | United States | $1.689B | 0.00 |
| Schrodinger (SDGR) | United States | $1.514B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.471B | 0.00 |
| Azenta (AZTA) | United States | $1.439B | 66.87 |
| Evolent Health (EVH) | United States | $1.367B | 116.40 |
| Omnicell (OMCL) | United States | $1.355B | 23.90 |
| Claritev (CTEV) | United States | $0.794B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.587B | 0.00 |
| Veradigm (MDRX) | United States | $0.536B | 0.00 |
| Standard BioTools (LAB) | United States | $0.486B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.465B | 0.00 |
| Talkspace (TALK) | United States | $0.443B | 132.50 |
| Outset Medical (OM) | United States | $0.362B | 0.00 |
| TruBridge (TBRG) | United States | $0.340B | 754.67 |
| Health Catalyst (HCAT) | United States | $0.275B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.268B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.217B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.169B | 0.00 |
| American Well (AMWL) | United States | $0.127B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.124B | 0.00 |
| Pulmonx (LUNG) | United States | $0.106B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.101B | 0.00 |
| CareCloud (CCLD) | United States | $0.100B | 3.81 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.087B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.075B | 0.00 |
| 111 (YI) | China | $0.065B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.050B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.046B | 0.00 |
| HeartBeam (BEAT) | United States | $0.044B | 0.00 |
| Zhongchao (ZCMD) | China | $0.028B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.021B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.009B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.003B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |